Chinese Pathologists Earn International Recognition at the 109th German Pathology Society Annual Meeting

The global pathology community witnessed a significant milestone during the 109th Annual Meeting of the German Pathology Society (DGP), held from May 28–30 in Augsburg, Germany. Chinese pathologists delivered outstanding academic contributions while receiving unprecedented international recognition, further strengthening China's growing influence in global pathology research and diagnostic innovation.

As a company dedicated to supporting modern pathology laboratories, Jinquan Medical congratulates the Chinese pathology community on these remarkable achievements and their continued contributions to global medical science.

Historic Recognition for Sino-German Pathology Collaboration

For the first time in its history, the German Pathology Society established the Distinguished International Partnership Award, presenting the inaugural honor to the Chinese Pathologist Committee of the Chinese Medical Association (CPCMA).

During the opening ceremony, DGP President Prof. Christoph Röcken personally awarded the certificate, recognizing decades of productive collaboration between Chinese and German pathologists. This milestone reflects the increasing importance of international cooperation in advancing precision diagnostics, molecular pathology, and translational medicine.

Such partnerships continue to drive innovation in areas including artificial intelligence-assisted diagnostics, digital pathology, and laboratory workflow optimization, shaping the future of pathology practice worldwide.

Chinese Emerging Scholars Present Cutting-Edge CNS Tumor Research

Representing the CPCMA Brain Neuropathology Group, three outstanding young researchers delivered highly regarded oral presentations that attracted considerable attention from international experts.

Novel Ependymoma-like Tumors with Mesenchymal Differentiation

Dr. Wang Leiming from Capital Medical University Xuanwu Hospital presented research exploring the genotype and phenotype characteristics of ependymoma-like tumors with mesenchymal differentiation. His work provided valuable insights into the clinicopathological and molecular features of this newly recognized tumor entity.

Discovery of GTAKA in the Chinese Population

Dr. Hu Wanming from Sun Yat-sen University Cancer Center introduced findings from a multicenter study defining GTAKA (Glioneuronal Tumor with ATRX Alteration, Kinase Fusion, and Anaplastic Features). The research systematically characterized its clinical presentation, molecular profile, and prognostic implications, contributing important evidence to central nervous system tumor classification.

New Insights into Deficient Mismatch Repair Glioblastomas

Dr. Yao Zhigang from Shandong First Medical University Provincial Hospital presented groundbreaking findings regarding primary glioblastomas with deficient mismatch repair mechanisms. His research highlighted distinct molecular characteristics and immune microenvironment features that may influence future diagnostic and therapeutic strategies.

Advancing Precision Pathology Through Global Academic Exchange

Following the presentations, Chinese delegates engaged in extensive discussions with international specialists on tumor pathogenesis, diagnostic standards, molecular classification, and prognostic assessment.

These academic exchanges demonstrate the growing importance of international collaboration in advancing precision medicine and improving diagnostic standards worldwide. The achievements presented at the conference also underscore the strength of China's multicenter research network and its increasing contribution to global medical science.

As pathology laboratories continue to embrace digital transformation, the demand for reliable laboratory infrastructure, advanced imaging technologies, and efficient workflow solutions is expected to grow across both clinical and research environments.

Looking Ahead

Guangdong Jinquan Medical Technology Co., Ltd. applauds the outstanding accomplishments of Chinese pathologists and their contributions to the international scientific community.

As a provider of pathology laboratory equipment and workflow solutions, the company remains committed to supporting innovation, collaboration, and excellence in pathology. We look forward to witnessing more groundbreaking discoveries that strengthen the global impact of Chinese pathology and contribute to the advancement of precision healthcare worldwide.

About Jinquan Medical

Looking to upgrade your pathology laboratory with reliable diagnostic equipment and workflow solutions?

Explore the latest innovations from Jinquan Medical and discover how modern laboratory technologies can help improve efficiency, diagnostic accuracy, and workflow management for hospitals, research institutions, and pathology laboratories worldwide.